May 29, 2024 · Form 4 insider transaction
SHERWIN STEPHEN A bought 25,000 shares of Neurocrine Biosciences, Inc. at $42.76 per share, a transaction worth $1.07M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.